Pretreatment serum lactate dehydrogenase is an independent prognostic factor for patients receiving neoadjuvant chemotherapy for locally advanced cervical cancer

For locally advanced cervical cancer (LACC), hypoxia is a characteristic property. This study aimed to investigate whether baseline lactic dehydrogenase (LDH) level, which is a marker of hypoxia, had clinical value in determining neoadjuvant chemotherapy (NACT) response and prognosis for LACC patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jing, Wu, Miao‐Fang, Lu, Huai‐Wu, Chen, Qing, Lin, Zhong‐Qiu, Wang, Li‐Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4971915/
https://www.ncbi.nlm.nih.gov/pubmed/27350066
http://dx.doi.org/10.1002/cam4.779

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4971915/
https://www.ncbi.nlm.nih.gov/pubmed/27350066
http://dx.doi.org/10.1002/cam4.779

Ejemplares similares